Home › Compare › MTAM vs JNJ

MTAM vs JNJ: Dividend Comparison 2026

MTAM yields 285714.29% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTAM wins by $1.734986541242196e+31M in total portfolio value
10 years
MTAM
MTAM
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full MTAM calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MTAM vs JNJ

📍 MTAM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTAMJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTAM + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MTAM pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTAM
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MTAM beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTAM + JNJ for your $10,000?

MTAM: 50%JNJ: 50%
100% JNJ50/50100% MTAM
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MTAM
No analyst data
Altman Z
-0.2
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTAM buys
0
JNJ buys
0
No recent congressional trades found for MTAM or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTAMJNJ
Forward yield285714.29% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$1.734986541242196e+31M$20.0K ✓
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓$827.78
Total dividends collected$1.734908400352195e+31M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MTAM vs JNJ ($10,000, DRIP)

YearMTAM PortfolioMTAM Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$28,582,129$28,571,428.57$10,676$355.77+$28.57M → MTAM
2$76,351,353,429$76,320,770,551.21$11,407$389.39+$76351.34M → MTAM
3$190,619,493,207,524$190,537,797,259,355.30$12,198$426.53+$190619493.20M → MTAM
4$444,781,927,427,195,200$444,577,964,569,463,100.00$13,056$467.62+$444781927427.18M → MTAM
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$13,987$513.12+$969967353346567.13M → MTAM
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$14,998$563.56+$1976961629315092992.00M → MTAM
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$16,098$619.52+$3.765923944594039e+21M → MTAM
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$17,295$681.69+$6.704681437057683e+24M → MTAM
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$18,599$750.82+$1.1156275836497015e+28M → MTAM
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$20,022$827.78+$1.734986541242196e+31M → MTAM

MTAM vs JNJ: Complete Analysis 2026

MTAM — Stock

Motos America Inc. does not have significant operations. It intends to buy and operate powersports dealerships, primarily European luxury motorcycle brands, including BMW Motorcycles, Triumph Motorcycles, and Ducati Motorcycles. Previously, it operated as an IT-solutions provider that offered a multi-dimensional e-commerce platform, which facilitates shopping, business, and trade, as well as integrates online and office transactions in a single application. The company was formerly known as Weconnect Tech International, Inc. and changed its name to Motos America Inc. in November 2021. The company was founded in 2015 and is based in Salt Lake City, Utah. As of October 26, 2021, Motos America Inc. operates as a subsidiary of Moto America, Inc.

Full MTAM Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MTAM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTAM vs SCHDMTAM vs JEPIMTAM vs OMTAM vs KOMTAM vs MAINMTAM vs ABBVMTAM vs MRKMTAM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.